Xcyte Therapies
Latest round
- Series D
Last raised
- Aug 2000
Total raised
- $28M
Investors
- 10
About Xcyte Therapies
Xcyte Therapies, Inc. is a US-based company that operates as a developer of therapeutic products that enhance the body’s natural immune responses to treat cancer, infectious diseases, and other medical conditions associated with weakened immune systems.
Who invested in Xcyte Therapies
10 investors across 1 round
See all investors in Xcyte Therapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Aug 16, 2000
Amount
$28M
Investors
Questions about Xcyte Therapies
Who invested in Xcyte Therapies?
Xcyte Therapies has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xcyte Therapies raised?
Xcyte Therapies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Xcyte Therapies last raise money?
Xcyte Therapies's most recent round on record is a Series D, in Aug 2000.
What does Xcyte Therapies do?
Xcyte Therapies is a biotechnology company.
Where is Xcyte Therapies headquartered?
Xcyte Therapies is headquartered in Seattle, US.
Which VCs invest in companies like Xcyte Therapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Xcyte Therapies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Xcyte Therapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.